Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as …
G Boivin, C Gilbert, A Gaudreau… - The Journal of …, 2001 - academic.oup.com
The emergence of mutations conferring ganciclovir resistance was evaluated in an open-
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as …
G Boivin, C Gilbert, A Gaudreau… - Journal of Infectious …, 2001 - search.ebscohost.com
The emergence of mutations conferring ganciclovir resistance was evaluated in an open-
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as …
G Boivin, C Gilbert, A Gaudreau… - The Journal of …, 2001 - europepmc.org
The emergence of mutations conferring ganciclovir resistance was evaluated in an open-
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
[PDF][PDF] Rate of Emergence of Cytomegalovirus (CMV) Mutations in Leukocytes of Patients with Acquired Immunodeficiency Syndrome Who Are Receiving …
G Boivin, C Gilbert, A Gaudreau, I Greenfield… - The Journal of Infectious …, 2001 - Citeseer
Methods Study population and samples. Patients with AIDS who had newly diagnosed CMV
retinitis were randomized to receive either 5 mg/kg iv ganciclovir twice a day for 3 weeks …
retinitis were randomized to receive either 5 mg/kg iv ganciclovir twice a day for 3 weeks …
Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as …
G Boivin, C Gilbert, A Gaudreau, I Greenfield, R Sudlow… - 2001 - cabidigitallibrary.org
The emergence of mutations conferring ganciclovir resistance was evaluated in an open-
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
[引用][C] Rate of Emergence of Cytomegalovirus (CMV) Mutations in Leukocytes of Patients with Acquired Immunodeficiency Syndrome Who Are Receiving …
G Boivin, C Gilbert, A Gaudreau, I Greenfield… - The Journal of …, 2001 - cir.nii.ac.jp
Rate of Emergence of Cytomegalovirus (CMV) Mutations in Leukocytes of Patients with
Acquired Immunodeficiency Syndrome Who Are Receiving Valganciclovir as Induction and …
Acquired Immunodeficiency Syndrome Who Are Receiving Valganciclovir as Induction and …
Rate of Emergence of Cytomegalovirus (CMV) Mutations in Leukocytes of Patients with Acquired Immunodeficiency Syndrome Who Are Receiving Valganciclovir as …
G Boivin, C Gilbert, A Gaudreau, I Greenfield… - The Journal of Infectious …, 2001 - JSTOR
The emergence of mutations conferring ganciclovir resistance was evaluated in an open-
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
[引用][C] Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as …
G BOIVIN, C GILBERT, A GAUDREAU… - The Journal of …, 2001 - pascal-francis.inist.fr
Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with
acquired immunodeficiency syndrome who are receiving valganciclovir as induction and …
acquired immunodeficiency syndrome who are receiving valganciclovir as induction and …
[PDF][PDF] Rate of Emergence of Cytomegalovirus (CMV) Mutations in Leukocytes of Patients with Acquired Immunodeficiency Syndrome Who Are Receiving …
G Boivin, C Gilbert, A Gaudreau… - The Journal of …, 2001 - researchgate.net
Methods Study population and samples. Patients with AIDS who had newly diagnosed CMV
retinitis were randomized to receive either 5 mg/kg iv ganciclovir twice a day for 3 weeks …
retinitis were randomized to receive either 5 mg/kg iv ganciclovir twice a day for 3 weeks …
Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as …
G Boivin, C Gilbert, A Gaudreau… - The Journal of …, 2001 - pubmed.ncbi.nlm.nih.gov
The emergence of mutations conferring ganciclovir resistance was evaluated in an open-
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …
label randomized clinical trial that compared oral valganciclovir with intravenous ganciclovir …